MRK

Merck & Co., Inc. · VIE:MRK

132.56 EUR−1.98 −1.47%

Merck & Co., Inc. (VIE:MRK) last traded at 132.56 EUR, down 1.47% on the day. Over the past year the stock is up 77.69%. Its 52-week range is 71.60 to 136.24. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open133.26

Day range132.56 – 133.30

52-week range71.60 – 136.24

Volume0

Average volume (10 days)12

Market cap (USD)368.89 B

P/E153.36

EPS (TTM) (USD)0.9792

Dividend yield2.27%

Beta (1 year)−0.0896

Revenue (TTM) (USD)67.19 B

Employees75.00 K

Performance

+0.88%1 week

+3.13%1 month

+19.44%3 months

+36.81%6 months

+47.95%Year to date

+77.69%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.